SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurobiological Tech (NTII) -- Ignore unavailable to you. Want to Upgrade?

To: Doug Markle who wrote (255)2/4/1998 2:00:00 AM
From: John Dwyer  Read Replies (1) | Respond to of 1494
 
Ah, sh**. I was afraid of this. I really don't understand this.
NASDAQ has been really tough lately on these weak, small cap
stocks. Why so many extensions? NTII was in violation for over
six months and had two extensions... they got the data they
wanted (more or less) and then... nothing. I'm puzzled.

Now life will be really tough for NTII. Not many companies come
back after delisting. Even with financing and a partnership,
doesn't NTII have to petition to get listed again? Could be
quite awhile before we see the small-cap list.

Looks like I'll have ample capital losses to offset gains this
year.... :o(

John



To: Doug Markle who wrote (255)2/4/1998 10:41:00 AM
From: lrb  Respond to of 1494
 
"We are now in discussions with potential individual and institutional investors..."

He mentions no discussions with drug companies. Does this
suggest that none are interested? Or would financing from
individual or institutional investors be preferred for some
reason. Is this a tradeoff between dilution or royalty-sharing?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News